Skip to main content

Alternative molecular mechanisms observed in cancer cells!!

Current anti-cancer drugs can be quite effective but too often, tumors are not fought off completely and end up returning. A recent study published in The FASEB Journal provides the first evidence that some cancer cells evade therapy by switching over to alternative molecular mechanisms that are not affected by existing anti-cancer treatments.
A research team from Innate Repair, a biotech venture of Technische Universität Dresden that develops novel therapeutics to fight cancer stem cells, conducted the study. To test their hypothesis of alternative molecular mechanisms or "cancer cell escape routes," researchers used cultured cells from brain cancer patients. They placed the cells in culture media designed to maintain them in three states: one where the cells utilized the established mechanisms to grow, one where they used the alternative mechanism, and one where they utilized both.
The researchers found that when the alternative mechanism was used, the cancer cells behaved very differently from when it was off. The cells' mechanical properties (shape, size, deformability), gene expression properties (i.e., which genes are turned on and which are turned off), and susceptibility to treatments changed dramatically. By modeling this alternative state, researchers were able to identify several treatments (both new to human use, as well as drugs already approved for other conditions) that specifically kill cancer cells in this alternative state.
"To kill the same cancer cell in one state, you need very different drugs than to kill it when it is in the alternative state," said Andreas Androutsellis-Theotokis, PhD, CEO of Innate Repair. "By focusing on those drugs that only kill cancer cells when they are using the alternative mechanism, we identified several drugs that, so far, probably have gone unnoticed."
Androutsellis-Theotokis and colleagues are hopeful that the drugs they identified that are already approved for other conditions could be repurposed in oncology relatively quickly, providing new options to cancer patients. In addition, their findings could potentially extend beyond brain cancer to cancer in general, as their prior work has demonstrated that this alternative molecular mechanism is also operational in several other types of cancer.
"This is a provocative lead that, if translated to animal studies, could lead to new drug development paradigms in oncology," said Thoru Pederson, PhD, Editor-in-Chief of The FASEB Journal.
Story Source:
Note: Content may be edited.

Comments

Popular posts from this blog

Major surgery associated with small, long term decline in brain functioning

Major surgery is associated with a small long-term decline in cognitive functioning -- equivalent, on average, to less than five months of natural brain ageing, finds a study in  The BMJ  today. But the odds of substantial cognitive decline also increase after surgery -- approximately doubling -- although the likelihood of this is much lower than after admission to hospital for a medical condition, the findings show. Cognitive decline is the gradual loss of brain functioning that occurs with ageing. It often starts decades before the conventional definition of old age and accelerates with ageing and the presence of an increasing number of underlying health conditions. Certain health issues, such as stroke, can lead to a large "step change" in cognitive decline, and there have been concerns that surgery might also do this, with some patients refusing beneficial surgical procedures as a result, say the researchers. Few previous studies have looked at the potential im...

Dark matter may be older than the Big Bang

Dark matter, which researchers believe make up about 80% of the universe's mass, is one of the most elusive mysteries in modern physics. What exactly it is and how it came to be is a mystery, but a new Johns Hopkins University study now suggests that dark matter may have existed before the Big Bang. The study, published August 7 in  Physical Review Letters , presents a new idea of how dark matter was born and how to identify it with astronomical observations. "The study revealed a new connection between particle physics and astronomy. If dark matter consists of new particles that were born before the Big Bang, they affect the way galaxies are distributed in the sky in a unique way. This connection may be used to reveal their identity and make conclusions about the times before the Big Bang too," says Tommi Tenkanen, a postdoctoral fellow in Physics and Astronomy at the Johns Hopkins University and the study's author. While not much is known about its origins,...

Scientists challenge notion of binary sexuality with naming of new plant species

A collaborative team of scientists from the US and Australia has named a new plant species from the remote Outback. Bucknell University biology postdoctoral fellow Angela McDonnell and professor Chris Martine led the description of the plant that had confounded field biologists for decades because of the unusual fluidity of its flower form. The discovery, published in the open access journal  PhytoKeys , offers a powerful example of the diversity of sexual forms found among plants. The new species of bush tomato discovered in remote Australia provides a compelling example of the fact that sexuality among Earth's living creatures is far more diverse -- and interesting -- than many people likely realize. Bucknell University postdoctoral fellow Angela McDonnell and biology professor Chris Martine led the study following an expedition last year to relocate populations of the new plant, which were first noted by Australian botanists during the 1970s. Herbarium specimens from th...